Evidence map›Paper›PMID 33221376›Full record

ArticleBiochimie2021

Manipulation of a cation-π sandwich reveals conformational flexibility in phenylalanine hydroxylase.

Emilia C Arturo, George W Merkel, Michael R Hansen, Sophia Lisowski, Deeanne Almeida, Kushol Gupta, Eileen K Jaffe

Open access · hybridAbstract read
In one paragraph

Article in Biochimie, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. FeHeliyon · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Emilia C ArturoMolecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, 10111, USA; Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, PA, 19102, USA.
George W MerkelMolecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, 10111, USA.
Michael R HansenMolecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, 10111, USA.
Sophia LisowskiMolecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, 10111, USA.
Deeanne AlmeidaMolecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, 10111, USA.
Kushol GuptaDepartment of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Eileen K JaffeMolecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, 10111, USA. Electronic address: eileen.jaffe@fccc.edu.
Fox Chase Cancer Center · USUniversity of Pennsylvania · US

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Dietmar J Kappes · 1985 to 2026
$138.8M
A New View of PAH Allostery - Correlation with Disease-Associated AllelesR01NS100081 · NINDS · RESEARCH INST OF FOX CHASE CAN CTR · PI JAFFE, EILEEN K · 2016 to 2020
$2.0M
NCI NIH HHS P30 CA006927NINDS NIH HHS R01 NS100081
6 · The paper itself

Abstract

Phenylalanine hydroxylase (PAH) is an allosteric enzyme that maintains phenylalanine (Phe) below neurotoxic levels; its failure results in phenylketonuria, an inborn error of amino acid metabolism. Wild type (WT) PAH equilibrates among resting-state (RS-PAH) and activated (A-PAH) conformations, whose equilibrium position depends upon allosteric Phe binding. The RS-PAH conformation of WT rat PAH (rPAH) contains a cation-π sandwich involving Phe80 that cannot exist in the A-PAH conformation. Phe80 variants F80A, F80D, F80L, and F80R were prepared and evaluated using native PAGE, size exclusion chromatography, ion exchange behavior, intrinsic protein fluorescence, enzyme kinetics, and limited proteolysis, each as a function of [Phe]. Like WT rPAH, F80A and F80D show allosteric activation by Phe while F80L and F80R are constitutively active. Maximal activity of all variants suggests relief of a rate-determining conformational change. Limited proteolysis of WT rPAH (minus Phe) reveals facile cleavage within a 4-helix bundle that is buried in the RS-PAH tetramer interface, reflecting dynamic dissociation of that tetramer. This cleavage is not seen for the Phe80 variants, which all show proteolytic hypersensitivity in a linker that repositions during the RS-PAH to A-PAH interchange. Hypersensitivity is corrected by addition of Phe such that all variants become like WT rPAH and achieve the A-PAH conformation. Thus, manipulation of Phe80 perturbs the conformational space sampled by PAH, increasing sampling of on-pathway intermediates in the RS-PAH and A-PAH interchange. The behavior of the Phe80 variants mimics that of disease-associated R68S and suggests a molecular basis for proteolytic susceptibility in PKU-associated human PAH variants.

Indexed as

Mutation, MissenseProtein MultimerizationAmino Acid SubstitutionAnimalsEnzyme StabilityHumansPhenylalanine HydroxylasePhenylketonuriasProtein Conformation, alpha-HelicalProtein Structure, QuaternaryRatsPhenylalanine HydroxylaseAllosteric regulationPhenylalanine hydroxylasePhenylketonuriaProtein conformationSingle residue substitution

Identifiers

PMID33221376
PMCPMC9856217
OpenAlexW3109960779

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.